Ekso Bionics appoints Corinna E. Lathan, Ph.D. to Board of Directors

EKSO BIONICS HOLDINGS, INC.

Board expanded to seven members; Lathan's term effective Dec. 25, 2021, expires at 2022 annual meeting.
Lathan is co-founder and CEO of AnthroTronix, a biomedical robotics and wearable tech company.
She also serves on board of PTC, Inc. (Nasdaq: PTC) and its Audit and Cybersecurity Committees.
No family relationships between Lathan and any director or executive officer.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Corinna E. Lathan

Director

CHRN · EKSO BIONICS HOLDINGS, INC.

Effective: 2021-12-25
Filed: December 28, 2021, 6:59 PM ET

On December 25, 2021, effective immediately, our Board of Directors (the “Board”) approved an increase in the size of the Board to seven people and appointed Corinna E. Lathan, Ph.D. to serve as a director of the Company

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Corinna E. Lathan was appointed as Director at EKSO BIONICS HOLDINGS, INC..

Action: appointed
Role: Director

Exact text from the filing

On December 25, 2021, effective immediately, our Board of Directors (the “Board”) approved an increase in the size of the Board to seven people and appointed Corinna E. Lathan, Ph.D. to serve as a director of the Company

View on SEC.gov

EKSO BIONICS HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001104659-21-153935

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.